Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 2
2001 5
2002 4
2003 2
2004 2
2005 2
2006 1
2008 4
2009 2
2010 1
2011 4
2012 2
2014 1
2015 1
2016 1
2021 1
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

31 results
Results by year
Filters applied: . Clear all
Page 1
Toll-like receptor 9 agonists as cancer therapeutics.
Holtick U, Scheulen ME, von Bergwelt-Baildon MS, Weihrauch MR. Holtick U, et al. Among authors: weihrauch mr. Expert Opin Investig Drugs. 2011 Mar;20(3):361-72. doi: 10.1517/13543784.2011.553187. Epub 2011 Jan 22. Expert Opin Investig Drugs. 2011. PMID: 21254877 Review.
CD40-activated B cells can be generated in high number and purity in cancer patients: analysis of immunogenicity and homing potential.
Kondo E, Gryschok L, Klein-Gonzalez N, Rademacher S, Weihrauch MR, Liebig T, Shimabukuro-Vornhagen A, Kochanek M, Draube A, von Bergwelt-Baildon MS. Kondo E, et al. Among authors: weihrauch mr. Clin Exp Immunol. 2009 Feb;155(2):249-56. doi: 10.1111/j.1365-2249.2008.03820.x. Epub 2008 Nov 24. Clin Exp Immunol. 2009. PMID: 19040609 Free PMC article. Review.
Analysis of Tie2-expressing monocytes (TEM) in patients with colorectal cancer.
Goede V, Coutelle O, Shimabukuro-Vornhagen A, Holtick U, Neuneier J, Koslowsky TC, Weihrauch MR, von Bergwelt-Baildon M, Hacker UT. Goede V, et al. Among authors: weihrauch mr. Cancer Invest. 2012 Mar;30(3):225-30. doi: 10.3109/07357907.2011.636114. Epub 2011 Dec 15. Cancer Invest. 2012. PMID: 22171993
Nail dystrophy due to dose-intensive chemotherapy.
Weihrauch MR, von Bergwelt-Baildon MS. Weihrauch MR, et al. Int J Hematol. 2009 Jul;90(1):6-7. doi: 10.1007/s12185-009-0355-9. Epub 2009 Jun 20. Int J Hematol. 2009. PMID: 19543953 No abstract available.
31 results